Versant Capital Management’s Doximity DOCS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$51.7K Buy
1,826
+1,683
+1,177% +$40.7K ﹤0.01% 1380
2026
Q2
$2.97K Sell
143
-1,465
-91% -$32.4K ﹤0.01% 2514
2026
Q1
$37.5K Buy
1,608
+1,590
+8,833% +$49.5K ﹤0.01% 1411
2025
Q4
$797 Sell
18
-49
-73% -$2.75K ﹤0.01% 2553
2025
Q3
$4.9K Hold
67
– – ﹤0.01% 2213
2025
Q2
$4.11K Sell
67
-186
-74% -$10.4K ﹤0.01% 2222
2025
Q1
$14.7K Buy
+253
New +$16K ﹤0.01% 1511

Other funds holding DOCS

Versant Capital Management's DOCS Position: Q3 2026 in Review

Versant Capital Management increased its Doximity (DOCS) stake by 1,177% in Q3 2026, buying an estimated $40.7K and bringing the position to 1,826 shares worth $51.7K. The position accounts for ﹤0.01% of the portfolio, ranked #1380.

Versant Capital Management first reported a position in DOCS in Q1 2025 and has held it in 7 quarters since. 32 funds tracked by Wall St. Rank hold DOCS as of Q3 2026.

  • Versant Capital Management held 1,826 shares of Doximity worth $51.7K as of Q3 2026.
  • Versant Capital Management bought 1,683 Doximity shares in Q3 2026, an estimated $40.7K.
  • Doximity made up ﹤0.01% of Versant Capital Management's portfolio in Q3 2026, its #1380 holding.
  • Versant Capital Management first reported a position in Doximity in Q1 2025 and has held it in 7 quarters since.
  • 32 funds tracked by Wall St. Rank held Doximity as of Q3 2026.

Based on Versant Capital Management's 13F filing for Q3 2026, filed 2 Oct 2026.